IPCA LABORATORIES LIMITED

IPCA Laboratories Limited (Singapore)

IPCA Laboratories Limited (Singapore) operates as a regional entity or subsidiary of IPCA Laboratories Limited, a prominent Indian multinational pharmaceutical company. While the parent company in India is a major manufacturer of Active Pharmaceutical Ingredients (APIs) and finished dosage forms, the Singapore office primarily functions as a trading, sales, marketing, and distribution hub for the Asia-Pacific region.

Its core activities include:

1. The distribution and sale of pharmaceutical products, including APIs and formulations, manufactured by its parent company.

2. Market development, sales support, and regulatory affairs for IPCA's product portfolio in regional markets.

3. Potentially managing regional supply chain operations and sourcing.

Therefore, IPCA Laboratories Limited (Singapore) is a **Trader** and Distributor, not a factory. It facilitates the commercial operations and market penetration of IPCA's pharmaceutical products within the region.

IPCA Laboratories Limited is an Indian multinational pharmaceutical company that manufactures and markets a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs). While they have a global presence and their products are sold in various markets worldwide, including Singapore, their primary manufacturing facilities are located in India.

The products they manufacture and sell, which would be available in markets like Singapore through distribution, generally fall into the following therapeutic categories:

* Antimalarials

* Pain Management (Analgesics and Anti-inflammatory drugs)

* Cardiovascular diseases

* Dermatology

* Anti-infectives and Antibiotics

* Gastroenterology

* Neuropsychiatry

* Respiratory

* Ophthalmology

* Nutraceuticals and Dietary Supplements

* Active Pharmaceutical Ingredients (APIs) for various therapeutic areas.